Factors associated with baseline mortality in Norwegian Atlantic salmon farming

• Published in: Scientific Reports
• Main Authors: Victor H. S. Oliveira, Katharine R. Dean, Lars Qviller, Carsten Kirkeby, Britt Bang Jensen
• Format: Article in Journal/Newspaper
• Language: English
• Published: Nature Portfolio 2021
• Subjects: Medicine; R; Science; Q; Norway; Atlantic salmon
• Online Access: https://doi.org/10.1038/s41598-021-93874-6; https://doaj.org/article/935914679e1b4a848bbd355710bcf6f4

Abstract In 2019, it was estimated that more than 50 million captive Atlantic salmon in Norway died in the final stage of their production in marine cages. This mortality represents a significant economic loss for producers and a need to improve welfare for farmed salmon. Single adverse events, such as algal blooms or infectious disease outbreaks, can explain mass mortality in salmon cages. However, little is known about the production, health, or environmental factors that contribute to their baseline mortality during the sea phase. Here we conducted a retrospective study including 1627 Atlantic salmon cohorts put to sea in 2014–2019. We found that sea lice treatments were associated with Atlantic salmon mortality. In particular, the trend towards non-medicinal sea lice treatments, including thermal delousing, increases Atlantic salmon mortality in the same month the treatment is applied. There were differences in mortality among production zones. Stocking month and weight were other important factors, with the lowest mortality in smaller salmon stocked in August–October. Sea surface temperature and salinity also influenced Atlantic salmon mortality. Knowledge of what affects baseline mortality in Norwegian aquaculture can be used as part of syndromic surveillance and to inform salmon producers on farming practices that can reduce mortality.